Archive \ Volume.14 2023 Issue 2

Development of Written Counseling Tool for Subcutaneous Anticoagulant Use in COVID-19 Patients

, ,


There is a lack of subcutaneous anticoagulant counseling tools for COVID-19 patients. This study aims to develop and validate a written counseling tool for subcutaneous anticoagulant use in COVID-19 patients. A prospective cohort study was performed with expert panels and patients. The tool was validated by hospital pharmacists using Content Validity Index (I-CVI), Scale-level-CVI (S-CVI), and Universal Acceptance (UA). Face validation by patients was determined using Item Acceptance Index (IAI), and Universal Acceptance (UA). Hospital pharmacists (n=26) were mostly female (n=18, 69.2%) and Chinese (n=20, 76.9%), with a mean age of 35.8±2.9 years. All items were assessed relevantly (n=18, 100%), I-CVIs ranging from 0.96-1.00 by hospital pharmacists. The average proportion of items, I-CVI average, (Sum of I-CVI/no. of items: 17.88/18) was reported as 0.99. S-CVI/UA (Sum of UA/no. of items: 15/18) was reported as 0.83, and S-CVI/Average (Sum of I-CVI/no. of items: 17.88/18) was reported as 0.99 indicating high content validity. Patients (n=28) involved in face validation of the construct were mostly female (n=19, 67.9%), Malay (n=46.4%), and tertiary educated (n=20, 71.4%) with a mean age of 38.0±9.8 years. All items were marked as relevant (n=18, 100%), with IAI ranging from 0.93-1.00, suggesting patients accepted each item of the construct. The average proportion of items was reported as 0.99 (Sum of IAI/no. of items: 17.82/18), indicating excellent acceptance and content comprehension among patients. The developed counseling tool is acceptable for anticoagulant education among COVID-19 patients.

Downloads: 340
Views: 1072

How to cite:
Low L, Islahudin F, Saffian SM. Development of Written Counseling Tool for Subcutaneous Anticoagulant Use in COVID-19 Patients. Arch Pharm Pract. 2023;14(2):19-24.
Low, L., Islahudin, F., & Saffian, S. M. (2023). Development of Written Counseling Tool for Subcutaneous Anticoagulant Use in COVID-19 Patients. Archives of Pharmacy Practice, 14(2), 19-24.

Download Citation

1.        Fong SJ, Dey N, Chaki J. An Introduction to COVID-19. J Nat Pub Health Emerg Coll. 2020:1-22. Available from: doi:10.1007/978-981-15-5936-5_1

2.        Ivan FH. Treatment of Coronavirus Disease 2019. Curr Opin HIV AIDS: review. Europe PMC. 2020;15(6):336-40. Available from: doi:10.1097/coh.0000000000000652

3.        Jayne L. Medical News Today UK. Medical News Today globally. Brighton BN1 1YR: Healthline Media UK; 2020. Available from:

4.        Belayneh K, Gobezie TT, Amsalu D, Melaku T, Desalegn T. Prevalence and risk factors of thromboembolism among patients with coronavirus disease-19: a systematic review and meta-analysis. Clin Appl Thromb Hemost. 2020;26(1):1-13. Available from: doi:10.1177/1076029620967083

5.        Corrado L, Giacomo I, Luca C, Maurizio C, Paola F, Tim S, et al. Venous and Arterial Thromboembolic Complications in Covid-19 Patients Admitted to an Academic Hospital in Milan, Italy. J Thromb Res. 2020;191:9-14. Available from: doi:10.1016/j.thromres.2020.04.024

6.        Florian B, Hippolyte M, Ines S, Mickael T, Hendy A, Laure F, et al. Pulmonary Embolism in Patients with Covid-19. Pneumonia. Eur Respir J. 2020;56(1):2001365. Available from: doi:10.1183/13993003.01365-2020

7.        Maarten C, Maarten F, Jasmien J, Margaretha VK, Isabelle L, Liesbeth M, et al. Venous Thromboembolism in Sars-Cov-2 Patients: Only a Problem in Ventilated Icu Patients, or Is There More to It? Eur Respir J. 2020;56(1):2001201. Available from: doi:10.1183/13993003.01201-2020

8.        Young JS, Hyunsook H, Mickael O, Florian B, Marie PR, Clarrisa V, et al. Pulmonary Embolism and Deep Vein Thrombosis in Covid-19: A Systematic Review and Meta-Analysis. Radiology. 2021;298(2):E70-E80. Available from: doi:10.1148/radiol.2020203557

9.        Lori K. Health & Discovery. Health & Discovery globally. Columbus, OH: The Ohio State University; 2022. Available from:

10.      Tarik H, Zyad K, Ayad AK. Coagulation and Anticoagulation in Covid-19. Blood Rev J. 2021;47:100761. Available from: doi:10.1016/j.blre.2020.100761

11.      Yalda S, Hassan T, Kheirollah G, Naser H, Mohammadreza J. Role of Pharmacist Counseling in Pharmacotherapy Quality Improvement. J Res Pharm Pract. 2016;5(2):132-7. Available from: doi:10.4103/2279-042X.179580

12.      Sunil L, Christianne LR, Anuj KD, Courtney C, Alexandra B, Svetlana KE, et al. Effect of a Pharmacist Intervention on Clinically Important Medication Errors after Hospital Discharge: Randomized Controlled Trial. Ann Intern Med. 2012;157(1):1-10. Available from: doi:10.7326/0003-4819-157-1-201207030-00003

13.      Sharon MF, Sylvia E, Katy B, Olga M, Brittany G, Nikki C, et al. Validity and Reliability of the Colorado Adult Joint Assessment Scale in Adults with Moderate-Severe Hemophilia A. J Thromb Haemost. 2020;18(2):285-94. Available from: doi: 10.1111/jth.14651

14.      Bahagian Amalan & Perkembangan Farmasi Kementerian Kesihatan Malaysia. Garis Panduan Kaunseling Ubat-Ubatan Edisi Ke-3. Malaysia: Pharmaceutical Services Programme Ministry of Health Malaysia; 2019. Available from:

15.      Kehinde OO, Leanne C, Luke RB. Development and Validation of an Oral Anticoagulation Knowledge Tool (AKT). PLoS One. 2016;11(6):e0158071. Available from: doi:10.1371/journal.pone.0158071

16.      Pharmaceutical Services Programme Ministry of Health Malaysia. Anticoagulation MTAC (AC-MTAC) Protocol 2nd Edition. Malaysia: Pharmaceutical Services Programme Ministry of Health Malaysia; 2020. Available from:

17.      Isabel BR, Jonathan DA, Karen AB, Joy CM. Development and validation of a new tool to measure the facilitators, barriers, and preferences to exercise in people with osteoporosis. BMC Musculoskelet Disord. 2017;18(1):540. Available from: doi:10.1186/s12891-017-1914-5

18.      MOH Clinical Pharmacy Practice Guidelines. Anticoagulation- Warfarin. Singapore: Minister of Health Singapore; 2006. Available from:

19.      Shi JC, Mo XK, Sun ZQ. Content Validity Index in Scale Development. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012;37(2):152-5. Available from: doi:10.3969/j.issn.1672-7347.2012.02.007

20.      Katy KS, Adriana SP, Ana PP, Ilka AR, Leonardo GP, Heloisa CT. Development and validation of an instrument to assess Brazilian healthcare professional providers’ knowledge on sickle cell disease. Hematol Transfus Cell Ther. 2019;41(2):145-52. Available from: doi:10.1016/j.htct.2018.08.003

21.      Zarina Z, Khairiah SM. Evaluating Trust in Public Administration: Attitude Towards E-Government as a Mediator. Multidiscip Res Agent Change. 2020;81:471-9. Available from: doi:10.15405/epsbs.2020.03.03.55

22.      Yusof MSB. ABC of Content Validation and Content Validity Index Calculation. Educ Resour. 2019;11(2):49-54. Available from: doi:10.21315/eimj2019.11.2.6

23.      Azwani M, Nor’ain MT, Noor Shah S. Evaluating the face and content validity of a Teaching and Learning Guiding Principles Instrument (Tlgpi): A Perspective Study of Malaysian Teacher Educators. Malaysian J Soc Space. 2016;12(3):11-21. Available from:

24.      Vahid Z, Akram G, Maryam R, Abbas A, Hamid AM, Ali-Reza N. Design and Implementation Content Validity Study: Development of an instrument for measuring Patient-Centered Communication. J Caring Sci. 2015;4(2):165-78. Available from: doi:10.15171/jcs.2015.017

25.      Sunil K, Rashanda R, Melissa HL, Laura EH, Jessica P, Akilah S, et al. Development of an illustrated medication schedule as a low-literacy patient education tool. Patient Educ Couns. 2007;66(3):368-77. Available from: doi:10.1016/j.pec.2007.01.020

26.      Magomedova UG, Khadartseva ZA, Grechko VV, Polivanova MN, Mishvelov AE, Povetkin SN, et al. The role of Covid-19 in the acute respiratory pathology formation in children. Pharmacophore. 2020;11(5):61-5.

27.      Eltayeb LB, Alharthi NS, Elmosaad YM, Waggiallah HA. Students’ perception on E. Learning and Remote Exams during COVID 19 Outbreak 2020. Int J Pharm Phytopharmacol Res. 2020;10(5):142-8.

28.      Smirnova EA, Stolyarova АN, Surnina KS, Denenberg YM, Dikova TV. Impact of the COVID-19 pandemic on the development of digital technologies in academic education. J Adv Pharm Educ Res. 2021;11(1):207-13.

29.      Agency for Healthcare Research and Quality. Medication Therapy Tools Help Pharmacists Educate Patients, Improve Adherence and Safety. Rockville, MD: Agency for Healthcare Research and Quality; 2017. Available from:

30.      Irene AK, Michelle AD, James PK. Medication management and adherence during the COVID-19 pandemic: Perspectives and experiences from low-and middle-income countries. Res Social Adm Pharm. 2021;17(1):2023-6. Available from: doi:10.1016/j.sapharm.2020.04.007

31.      Adelline T, Agnes BN, Rosalind PR, Ronnie K, Agnes K, Barbara C, et al. Acceptability of a Mobile Phone Support Tool (Call for Life Uganda) for Promoting Adherence to Antiretroviral Therapy Among Young Adults in a Randomized Controlled Trial: Exploratory Qualitative Study. JMIR Mhealth Uhealth. 2021;9(6):e17418. Available from: doi:10.2196/17418

32.      Karen O, Davina L, Howard BA, Shoshanna HG, Ronak B, Tai H, et al. Impact of patient-centered discharge tools: A Systematic Review. J Hosp Med. 2017;12(2):110-7. Available from: doi:10.12788/jhm.2692

33.      Elisabet FG, Adelina MS, Trinidad LV, Maria AS, Silvia NP, Carmen EM. Content Validation through Expert Judgement of an Instrument on the Nutritional Knowledge, Beliefs, and Habits of Pregnant Women. Nutrients. 2020;12(4):1136. Available from: doi:10.3390/nu12041136

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.